Bipolar Disorder

Bipolar disorder is a mental health condition characterized by extreme mood swings, including episodes of mania and depression. It is a prevalent condition affecting individuals of all ages and can vary in severity and duration, often requiring long-term management.

Over time, research has advanced from viewing bipolar disorder merely as a behavioral issue to understanding its complex mechanisms involving genetic, neurobiological, and environmental factors.

This evolving understanding has been crucial in developing current therapeutic approaches that aim to stabilize mood swings, improve overall functioning, and address the psychological components of the disorder.

iNGENū's team of experienced researchers and clinicians specializes in designing and conducting innovative studies. By leveraging enhanced trial design and comprehensive patient-centric strategies, we are committed to accelerating the development of new treatments for bipolar disorder.

50%

of people with Bipolar Disorder have a co-occuring mental health condition, like anxiety or substance use



70%

of people with Bipolar Disorder respond well to a combination of mood stabilizers and psychotherapy

 

BPD

affects Men and Women equally, although the type of Bipolar Disorder varies between genders

 



Our clinical team has over

120

years of combined clinical trial experience

Download Our Paper

Fill out this form to download our white paper on how to overcome the biggest obstacles in conducting an Bipolar Disorder clinical trial.

iNGENu CRO - BPD Whitepaper

In light of the impact Bipolar Disorder has on individuals and society as a whole, continued research efforts are crucial to improve diagnosis, treatment, and ultimately, patients' quality of life.

The development of clinical trial protocols that meet FDA approval standards is crucial for the success of new Bipolar Disorder treatments.